HEALTH
Rituximab Tied to Increased Infection Risk in RRMS
![Rituximab Tied to Increased Infection Risk in RRMS](https://connecticutnewspress.com/wp-content/uploads/2024/06/11553-rituximab-tied-to-increased-infection-risk-in-rrms.jpg)
The B-cell–depleting drug rituximab was associated with a twofold increased risk for infection in patients with relapsing-remitting multiple sclerosis (RRMS), regardless of treatment duration or whether patients had received other disease-modifying therapy (DMT) or had a short disease duration. “We found an approximately doubled risk of serious infections with rituximab compared with other DMTs…